Infection with SARS-CoV-2 variant B.1.1.7 detected in a group of dogs and cats with suspected myocarditis.


Journal

The Veterinary record
ISSN: 2042-7670
Titre abrégé: Vet Rec
Pays: England
ID NLM: 0031164

Informations de publication

Date de publication:
11 2021
Historique:
revised: 10 07 2021
received: 08 04 2021
accepted: 28 08 2021
pubmed: 6 11 2021
medline: 16 11 2021
entrez: 5 11 2021
Statut: ppublish

Résumé

Domestic pets can contract severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; however, it is unknown whether the UK B.1.1.7 variant can more easily infect certain animal species or increase the possibility of human-to-animal transmission. This is a descriptive case series reporting SARS-CoV-2 B.1.1.7 variant infections in a group of dogs and cats with suspected myocarditis. The study describes the infection of domestic cats and dogs by the B.1.1.7 variant. Two cats and one dog were positive to SARS-CoV-2 PCR on rectal swab, and two cats and one dog were found to have SARS-CoV-2 antibodies 2-6 weeks after they developed signs of cardiac disease. Many owners of these pets had developed respiratory symptoms 3-6 weeks before their pets became ill and had also tested positive for COVID-19. Interestingly, all these pets were referred for acute onset of cardiac disease, including severe myocardial disorders of suspected inflammatory origin but without primary respiratory signs. These findings demonstrate, for the first time, the ability for pets to be infected by the B.1.1.7 variant and question its possible pathogenicity in these animals.

Sections du résumé

BACKGROUND
Domestic pets can contract severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; however, it is unknown whether the UK B.1.1.7 variant can more easily infect certain animal species or increase the possibility of human-to-animal transmission.
METHODS
This is a descriptive case series reporting SARS-CoV-2 B.1.1.7 variant infections in a group of dogs and cats with suspected myocarditis.
RESULTS
The study describes the infection of domestic cats and dogs by the B.1.1.7 variant. Two cats and one dog were positive to SARS-CoV-2 PCR on rectal swab, and two cats and one dog were found to have SARS-CoV-2 antibodies 2-6 weeks after they developed signs of cardiac disease. Many owners of these pets had developed respiratory symptoms 3-6 weeks before their pets became ill and had also tested positive for COVID-19. Interestingly, all these pets were referred for acute onset of cardiac disease, including severe myocardial disorders of suspected inflammatory origin but without primary respiratory signs.
CONCLUSIONS
These findings demonstrate, for the first time, the ability for pets to be infected by the B.1.1.7 variant and question its possible pathogenicity in these animals.

Identifiants

pubmed: 34738231
doi: 10.1002/vetr.944
pmc: PMC8661638
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e944

Subventions

Organisme : French National Agency for Research and IDEXLYON project of Université de Lyon as part of the 'Programme Investissements d'Avenir
ID : ANR-RA-COVID-19
Organisme : French National Agency for Research and IDEXLYON project of Université de Lyon as part of the 'Programme Investissements d'Avenir
ID : ANR-16-IDEX-0005

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 British Veterinary Association.

Références

Cell Mol Immunol. 2021 Feb;18(2):318-327
pubmed: 33408342
Intern Emerg Med. 2021 Aug;16(5):1123-1129
pubmed: 33484452
Transbound Emerg Dis. 2021 May 6;:
pubmed: 33955193
J Med Virol. 2020 Nov;92(11):2328-2331
pubmed: 32401374
Vet Rec. 2021 Nov;189(9):e944
pubmed: 34738231
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
Vet Rec. 2021 Apr;188(8):e247
pubmed: 33890314
One Health. 2021 Jun;11:100192
pubmed: 33169106
Int J Mol Med. 2020 Sep;46(3):957-964
pubmed: 32705153
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Emerg Infect Dis. 2020 Dec;26(12):3071-3074
pubmed: 32938527
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Circulation. 2021 Jan 5;143(1):21-32
pubmed: 33166189
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Cardiovasc Revasc Med. 2021 Feb;23:107-113
pubmed: 32847728
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
J Pathol. 2021 Jul;254(4):307-331
pubmed: 33586189

Auteurs

Luca Ferasin (L)

The Ralph Veterinary Referral Centre, Marlow, Buckinghamshire, UK.
Specialist Veterinary Cardiology Consultancy, Four Marks, Hampshire, UK.

Matthieu Fritz (M)

Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier, IRD, CNRS), Montpellier, France.

Heidi Ferasin (H)

The Ralph Veterinary Referral Centre, Marlow, Buckinghamshire, UK.
Specialist Veterinary Cardiology Consultancy, Four Marks, Hampshire, UK.

Pierre Becquart (P)

Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier, IRD, CNRS), Montpellier, France.

Sandrine Corbet (S)

Laboratoire de Virologie, Centre Hospitalo-Universitaire, Caen, France.

Meriadeg Ar Gouilh (M)

Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier, IRD, CNRS), Montpellier, France.
Laboratoire de Virologie, Centre Hospitalo-Universitaire, Caen, France.
Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Univ, UNICAEN, Caen, France.

Vincent Legros (V)

CIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Université de Lyon, VetAgro Sup, Marcy-l'Etoile, France.

Eric M Leroy (EM)

Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier, IRD, CNRS), Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH